TY  - JOUR
A1  - Pimentel-Elardo, Sheila M.
A1  - Buback, Verena
A1  - Gulder, Tobias A. M.
A1  - Bugni, Tim S.
A1  - Reppart, Jason
A1  - Bringmann, Gerhard
A1  - Ireland, Chris M.
A1  - Schirmeister, Tanja
A1  - Hentschel, Ute
T1  - New Tetromycin Derivatives with Anti-Trypanosomal and Protease Inhibitory Activities
JF  - Marine drugs
N2  - Four new tetromycin derivatives, tetromycins 1-4 and a previously known one, tetromycin B (5) were isolated from Streptomyces axinellae Pol001(T) cultivated from the Mediterranean sponge Axinella polypoides. Structures were assigned using extensive 1D and 2D NMR spectroscopy as well as HRESIMS analysis. The compounds were tested for antiparasitic activities against Leishmania major and Trypanosoma brucei, and for protease inhibition against several cysteine proteases such as falcipain, rhodesain, cathepsin L, cathepsin B, and viral proteases SARS-CoV M(pro), and PL(pro). The compounds showed antiparasitic activities against T. brucei and time-dependent inhibition of cathepsin L-like proteases with K(i) values in the low micromolar range.
KW  - cysteine protease
KW  - drugs
KW  - streptomyces
KW  - discovery
KW  - anti-trypanosomal
KW  - protease inhibition
KW  - Streptomyces axinellae
KW  - marine sponge
KW  - tetromycin
Y1  - 2011
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-141171
VL  - 9
IS  - 10
ER  - 
TY  - JOUR
A1  - Pimentel-Elardo, Sheila M.
A1  - Buback, Verena
A1  - Gulder, Tobias A. M.
A1  - Bugni, Tim S.
A1  - Reppart, Jason
A1  - Bringmann, Gerhard
A1  - Ireland, Chris M.
A1  - Schirmeister, Tanja
A1  - Hentschel, Ute
T1  - New Tetromycin Derivatives with Anti-Trypanosomal and Protease Inhibitory Activities
N2  - Four new tetromycin derivatives, tetromycins 1–4 and a previously known one, tetromycin B (5) were isolated from Streptomyces axinellae Pol001T cultivated from the Mediterranean sponge Axinella polypoides. Structures were assigned using extensive 1D and 2D NMR spectroscopy as well as HRESIMS analysis. The compounds were tested for antiparasitic activities against Leishmania major and Trypanosoma brucei, and for protease inhibition against several cysteine proteases such as falcipain, rhodesain, cathepsin L, cathepsin B, and viral proteases SARS-CoV Mpro, and PLpro. The compounds showed antiparasitic activities against T. brucei and time-dependent inhibition of cathepsin L-like proteases with Ki values in the low micromolar range.
KW  - Biologie
KW  - tetromycin
KW  - anti-trypanosomal
KW  - protease inhibition
KW  - Streptomyces axinellae
KW  - marine sponge
Y1  - 2011
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-75465
ER  - 
TY  - JOUR
A1  - Pimentel-Elardo, Sheila Marie
A1  - Kozytska, Svitlana
A1  - Bugni, Tim S.
A1  - Ireland, Chris M.
A1  - Moll, Heidrun
A1  - Hentschel, Ute
T1  - Anti-Parasitic Compounds from Streptomyces sp. Strains Isolated from Mediterranean Sponges
N2  - Actinomycetes are prolific producers of pharmacologically important compounds accounting for about 70% of the naturally derived antibiotics that are currently in clinical use. In this study, we report on the isolation of Streptomyces sp. strains from Mediterranean sponges, on their secondary metabolite production and on their screening for anti-infective activities. Bioassay-guided isolation and purification yielded three previously known compounds namely, cyclic depsipeptide valinomycin, indolocarbazole alkaloid staurosporine and butenolide. This is the first report of the isolation of valinomycin from a marine source. These compounds exhibited novel anti-parasitic activities specifically against Leishmania major (valinomycin IC50 < 0.11 μM; staurosporine IC50 5.30 μM) and Trypanosoma brucei brucei (valinomycin IC50 0.0032 μM; staurosporine IC50 0.022 μM; butenolide IC50 31.77 μM). These results underscore the potential of marine actinomycetes to produce bioactive compounds as well as the re-evaluation of previously known compounds for novel anti-infective activities.
KW  - Biologie
KW  - marine sponges
KW  - Streptomyces
KW  - valinomycin
KW  - staurosporine
KW  - butenolide
KW  - anti-parasitic
Y1  - 2010
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-68312
ER  -